Boston Scientific WallFlexâ„¢ Esophageal Stent Gains CE Mark For The Treatment Of Refractory Benign Esophageal Strictures

[PR Newswire] – NATICK, Mass., Feb. 14, 2014 /PRNewswire/ — Boston Scientific Corporation (BSX) has received CE Mark in Europe for its WallFlexâ„¢ Esophageal Fully Covered Stent to treat refractory benign esophageal strictures. Benign esophageal strictu more

View todays social media effects on BSX

View the latest stocks trending across Twitter. Click to view dashboard

See who Boston is hiring next, click here to view